We continue to add new resources to our COVID-19: Information for NIH Applicants and Recipients of NIH Funding webpage. We hope they are helpful in navigating this unprecedented situation. Here is a summary of what’s new since the last Nexus.
It has been four months since the COVID-19 pandemic shuttered laboratories and clinical studies across the country and the world. On April 10, only a few weeks into the pandemic, the Congressional Research Service (CRS) published a report describing the consequences of social distancing and other pandemic mitigation measures. These consequences included laboratory closures, de-prioritized projects, cancellation of meetings and conferences, loss of revenue, disrupted personnel processes, supply-chain interruptions, and, overlying all of these, a great deal of uncertainty. Since the CRS report was issued, we have learned more about the pandemic’s effects on non-COVID research and on the research workforce.
21 Comments
As we continue to address the effects of COVID-19 and as some states and institutions are considering reopening, we would like to share some administrative flexibilities that NIH is providing to research institutions with laboratory animal programs. These flexibilities are meant to assure personnel safety and animal welfare while enabling research personnel to prioritize and preserve research efforts. Some of these can be useful in reducing administrative burden, too.
1 Comments
As our nation looks to begin reopening, NIH continues to track how well our policies are meeting the evolving needs of the research community. In this post we would like to highlight allowance of preliminary data as a new special exception to our post submission materials policy and our guidance for reviewers.
12 Comments
Preprints – complete, public drafts of scientific documents that are not yet certified by peer reviewed – are playing a key role in accelerating dissemination of research on the SARS-CoV-2 virus and COVID-19, highlighting a need for broader discovery and distribution of early research results in literature searches. Responding to this urgent need, the National Library of Medicine (NLM) has launched the NIH Preprint Pilot, which will test the viability of making preprints searchable in PubMed Central (PMC) and, discoverable in PubMed, starting with preprints reporting NIH-supported COVID-19 research.
4 Comments
As we continue to address the effects of the COVID-19 public health emergency on NIH-supported research, we are aware of applicant concerns about the potential impact of this temporary emergency situation on the outcome of peer review. We want to reassure applicants that we released guidance for reviewers that makes it clear that, when reviewing applications during the coronavirus pandemic national emergency, reviewers should assume that issues resulting from the coronavirus pandemic, such as the following, should not affect scores.
6 Comments
Yes, if the alternative methods would provide a meaningful experience related to the goals of the program.
0 Comments
Institutions affected by COVID-19 will be allowed to submit post-submission grant application materials to revise information that was submitted in an application as long as the materials are received at least fourteen days before the start of the review meeting. The post-submission grant application materials policy remains in effect. Only the types of materials allowed under the policy can be accepted. A letter of explanation (one page max.) is required.
2 Comments
We continue to add new resources to our COVID-19: Information for NIH Applicants and Recipients of NIH Funding webpage. We hope they are helpful in helping you navigate this unprecedented situation. Here is a summary of what’s new since the last Nexus.
0 Comments
In the past few months, the scientific community has ramped up research in response to the SARS‑CoV‑2 pandemic; dozens of peer-reviewed articles and preprints on this topic are being added to the literature every day (Figure 1). This rapidly expanding effort has created challenges for scientists and the medical community who need to analyze thousands of scholarly articles for insights on the virus.
10 Comments
2 Comments